A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA

Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates

(2018) Babak Moazen et al.   EPIDEMIOLOGIC REVIEWS

Dynamic Models of Infectious Disease Transmission in Prisons and the General Population

(2018) Martial L Ndeffo-Mbah et al.   EPIDEMIOLOGIC REVIEWS

Micro-elimination – A path to global elimination of hepatitis C

(2017) Jeffrey V. Lazarus et al.   JOURNAL OF HEPATOLOGY

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis

(2016) Natasha K. Martin et al.   HEPATOLOGY

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

(2016) E. J. Aspinall et al.   JOURNAL OF VIRAL HEPATITIS

Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners

(2016) Adeeba Kamarulzaman et al.   LANCET

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees

(2016) Kate Dolan et al.   LANCET

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

(2016) Gui-Qi Zhu et al.   MEDICINE

Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons

(2015) Tianhua He et al.   ANNALS OF INTERNAL MEDICINE

Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations

(2014) Shan Liu et al.   ANNALS OF INTERNAL MEDICINE

Multicenter study on the discontinuation and efficacy of chronic hepatitis C treatment in the Spanish penitentiary population (EPIBAND study)

(2014) José de Juan et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Directly observed therapy for chronic hepatitis C: A randomized clinical trial in the prison setting

(2014) Pablo Saiz de la Hoya et al.   Gastroenterologia y Hepatologia

HCV infected prisoners: should they be still considered a difficult to treat population?

(2013) Fabio Iacomi et al.   BMC INFECTIOUS DISEASES

Safety and Effectiveness of a Nurse-Led Outreach Program for Assessment and Treatment of Chronic Hepatitis C in the Custodial Setting

(2013) Andrew R. Lloyd et al.   CLINICAL INFECTIOUS DISEASES

Comparison of hepatitis C virus treatment between incarcerated and community patients

(2012) John P. Rice et al.   HEPATOLOGY

High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C

(2010) John P Bate et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery

Treatment Outcomes With Pegylated Interferon and Ribavirin for Male Prisoners With Chronic Hepatitis C

(2009) Kara W. Chew et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Clinical Outcomes of Hepatitis C Treatment in a Prison Setting: Feasibility and Effectiveness for Challenging Treatment Populations

(2008) Duncan Smith‐Rohrberg Maru et al.   CLINICAL INFECTIOUS DISEASES

Access to Treatment of Hepatitis C in Prison Inmates

(2008) Paul Strock et al.   DIGESTIVE DISEASES AND SCIENCES

Treating hepatitis C in the prison population is cost-saving

(2008) Jennifer A. Tan et al.   HEPATOLOGY